Delivery Order SPE2DE21D0005-SPE2D625F1V53
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The contract is for the supply of the company's APLIGRAF product, a specialized skin substitute used in medical treatments. The $1,239.95 fixed-price contract with economic price adjustment has a completion date of November 13, 2024....
- This is a $1,239.95 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Organogenesis Inc., a regenerative medicine company. The order is for the company's APLIGRAF product, which is a wound dressing and tissue regeneration solution. Organogenesis has been awarded numerous prime federal contracts by the DLA and Department of Veterans Affairs (VA) to provide advanced wound care and surgical products. This specific award is not associated with a set-aside program....
- This is a federal contract award from the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit manufacturer of regenerative medical products. The $1,239.95 fixed-price delivery order is for the supply of APLIGRAF, a skin substitute product. The contract does not have a set-aside designation, indicating Organogenesis competes as a standard commercial vendor. Organogenesis is a key supplier of wound care, surgical biologics, and tissue regeneration products to federal healthcare...
- This federal contract award to Organogenesis Inc., a leading regenerative medicine company, is for the delivery of APLIGRAF, a wound care product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,239.95 fixed-price delivery order, which includes an economic price adjustment, has a completion date of June 11, 2024. Organogenesis Inc. is a for-profit manufacturer of goods and has been a registered federal contractor since 2006. The company holds several significant Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract is for the provision of APLIGRAF, a skin substitute product, with a fixed price and economic price adjustment pricing type. The contract has a ceiling value of $1,239.95 and runs through June 3, 2025. Organogenesis is a for-profit manufacturer registered in the System for Award...
- This is a federal contract award to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of APLIGRAF, a skin substitute product. The contract is a Delivery Order, with a Ceiling Value of $1,239.95, and a Fixed Price with Economic Price Adjustment pricing type. The contract has an Ultimate Completion Date of April 17, 2025. Organogenesis Inc. is a for-profit...
- This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support to Organogenesis Inc., a for-profit manufacturer of advanced regenerative medicine products. The $1,239.95 fixed-price contract is for the supply of the APLIGRAF wound care product, with a period of performance through November 1, 2024. Organogenesis is an established federal contractor, holding several significant Indefinite Delivery Vehicles (IDVs) with the Department of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading manufacturer of regenerative medicine products. The order, valued at $1,239.95, is for the company's APLIGRAF skin substitute product. The order is a fixed-price contract with economic price adjustment, and does not utilize a set-aside designation. Organogenesis Inc. is a long-standing federal contractor, providing a range of wound care and surgical biologics to the...
- This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The contract is a delivery order for APLIGRAF, a skin substitute product. The contract has no set-aside designation, indicating Organogenesis competed as a standard commercial vendor. Organogenesis is a key supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare...
- This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Organogenesis Inc., a leading regenerative medicine company. The contract, valued at $2,479.90, is for the delivery of APLIGRAF wound care products to the DLA's Medical Supply Chain program. The contract has a period of performance through March 25, 2024 and utilizes a fixed price with economic price adjustment pricing structure. This award is part of a larger $49.5 million indefinite delivery...
- SPE2DE21D0005Indefinite Delivery Contract
- SPE2DE21D0005-SPE2D625F1V53Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit manufacturer of regenerative medical products. The $1,239.95 fixed-price contract with economic price adjustment is for the delivery of APLIGRAF, a skin substitute product. The contract has an ultimate completion date of March 10, 2025. Organogenesis is a key supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare agencies, primarily the Department of Veterans Affairs (VA) and the DLA. The company holds several significant federal Indefinite Delivery Vehicles (IDVs) with the VA and DLA, demonstrating its strategic position in government medical procurement. This contract award is not designated as a set-aside.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/5/25 |